A comprehensive view of eli lilly & co.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Korean Intellectual Property Office Receives Eli Lilly and Company's Patent Application for 2,6-Diamino Pyridine Compounds
Published: September 29, 2023 by Chemical Patent News
AstraZeneca, Bristol Myers Squibb, and Merck to participate in the first round of drug price negotiations under the Inflation Reduction Act; J&J, Novartis, Lilly, Novo Nordisk, and Amgen yet to declare their stance
Published: September 28, 2023 by FiercePharma
FDA adds intestinal blockage warning to Novo Nordisk's Ozempic label, following reports of serious side effects with GLP-1 drugs; the issue is already noted on labels of Eli Lilly’s Mounjaro and Novo’s Wegovy
Published: September 28, 2023 by FiercePharma
INTERNATIONAL PATENT: ELI LILLY AND COMPANY FILES APPLICATION FOR "SARM1 RNA INTERFERENCE AGENTS"
Published: September 27, 2023 by U.S. Fed News
INTERNATIONAL PATENT: ELI LILLY AND COMPANY FILES APPLICATION FOR "CAPSULE FOR GASTROINTESTINAL SAMPLING"
Published: September 27, 2023 by U.S. Fed News

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count